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A B S T R A C T
Background. Iodinated contrast media (CM) used in angiography and computed tomography (CT) scans is an important cause of acute kidney injury (AKI) in hospitalized patients undergoing surgery. Contrast-induced nephropathy leads to AKI soon after CM administration. The aim of the study was to determine whether the timing of contrast media exposure related to diagnostic imaging during the immediate perioperative period influences the risk of post-operative AKI. Methods. All patients aged 18 years or above who underwent diagnostic imaging within 7 days of non-cardiac surgery between 1 January 2003 and 31 December 2013 in the Tayside region of Scotland, UK were included in the analysis. The primary outcome of AKI was defined using the Kidney Disease: Improving Global Outcomes creatinine-based criteria. Multiple logistic regressions were performed to identify predictors for AKI. Results. Of 9300 patients, 6224 were exposed to CM in the immediate perioperative period and 3076 were not. Postoperative AKI occurred in 678 (10.9%) of the 6224 patients who were exposed to CM. On multiple logistic regression, independent predictors of post-operative AKI were increasing age, male gender, lower baseline renal function and treatment with angiotensin-converting enzyme inhibitors or angiotensin receptor blockers. Timing of CM exposure did not affect risk of developing AKI, odds ratio 0.972 (95% confidence interval 0.935-1.010), P ¼ 0.146. Conclusions. For patients who have either just had or are soon to undergo general surgical procedures there appears to be no need to limit CT scan quality by avoiding the administration of CM. These patients may benefit from the increased diagnostic utility of contrast-enhanced CT scans without increasing their risk of perioperative AKI.
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I N T R O D U C T I O N
Acute kidney injury (AKI) affects one in five people hospitalized, with a significant proportion of cases estimated to be preventable [1] . It is associated with increased mortality of up to 50% in severe AKI, but even mild, transient AKI is associated V C The Author 2017. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved.
with both increased long-term mortality and the future development of chronic kidney disease (CKD) [2, 3] .
For many years it has been widely accepted that one of the leading causes of AKI in hospitalized patients is iodinated contrast media (CM) used in angiography and computed tomography (CT) scans [4] , with contrast-induced nephropathy (CIN) leading to AKI soon after CM administration. The risk of CIN is negligible in patients with normal renal function but the incidence appears to rise to as high as 25% in patients with pre-existing renal impairment or in the presence of risk factors such as diabetes, advanced age and use of certain concurrent medication. CIN is reported to be the third most common cause of new AKI in hospitalized patients, after decreased renal perfusion and medication responsible for 11% of cases [5] .
Another important cause of AKI in hospitalized patients is surgery. The incidence of AKI after surgery ranges from 18% to 47% and mortality from 1% to 30% depending on which AKI definitions are applied. Historically it was difficult to reliably establish the incidence of AKI due to the lack of a universally accepted definition. Using the now widely accepted Kidney Disease: Improving Global Outcomes (KDIGO) criteria we have shown that rates of AKI ranged from 6% in orthopaedic surgery to 25% in vascular surgery [6] , highlighting the extent of the current problem.
An apparently synergistic relationship between the 'double hits' of surgery and CM exposure has been reported in cardiac surgery where operations often take place soon after angiography. The incidence of post-operative AKI is correspondingly high at 10-25% depending on presence of pre-existing renal impairment. A meta-analysis of studies has advocated that as long a gap as is clinically feasible be allowed between the nephrotoxic insults of surgery and CM exposure [7] . This evidence presents a strong theoretical risk that CM exposure and surgery are separate and complementary risk factors for AKI, and that modifying clinical practice by reducing CM exposure in the perioperative period may be a potentially effective target to reduce a potentially avoidable risk of AKI in the wider general surgical population.
The aim of our study was to determine whether the timing of CM exposure related to diagnostic imaging during the immediate perioperative period influences the risk of post-operative AKI in the general surgical population.
M A T E R I A L S A N D M E T H O D S

Study population
Adults aged 18 years or above who underwent non-cardiac surgery and a diagnostic imaging investigation including the administration of CM within 7 days of the surgical procedure in a hospital in the Tayside region of Scotland from 1 January 2003 to 31 December 2013 were included in the study. Patients who were receiving chronic renal replacement therapy (RRT) or had missing pre-or post-operative creatinines were excluded.
Ethical statement
Anonymized record linkage was conducted according to Health Informatics Centre (HIC), University of Dundee [8] standard operating procedure. The Tayside Research Ethics Committee does not require submission of individual studies that follow this standard operating procedure, which is Caldicott Guardian approved. The study manuscript has been prepared in adherence to the recommendations of the strengthening of the reporting of observational studies in epidemiology (STROBE) workshop [9] .
Data sources
Data were linked using the HIC at the University of Dundee [8] . HIC enables anonymized health record linkage for the population of Tayside (n ¼ 400 000) using a unique identifying Community Health Index number. Data were linked between the following data sets: Scottish Morbidity Record of hospital admissions (SMR01), laboratory results, medicines dispensed by community pharmacies, Scottish Index of Multiple Deprivation (SIMD), the Scottish Care Initiative-Diabetes Collaboration, the Scottish Renal Registry and the Healthcare Software Solutions Computerised Radiology Information System (HSS CRIS). SMR01 provides information on age, sex, postcode, admission and discharge dates and operation procedure codes. Creatinine measurements were obtained from the laboratory system. Deprivation category was obtained from SIMD and the Scottish Care Initiative-Diabetes Collaboration provided information on diabetes type and date of diagnosis. Patients receiving chronic dialysis or post renal transplant were identified using the Scottish Renal Registry. Diagnostic imaging investigations involving the administration of CM were identified from the HSS CRIS radiology system by their specific examination codes with data extracted on type and volume of CM administered.
Outcome
The outcome of interest was the development of any severity of AKI (Stages 1-3) during the first week post-operatively. AKI severity was defined using KDIGO criteria [10] . These criteria were applied using serum creatinine at baseline (most recent prior to surgery within 6 months) as preoperative measurement and maximal serum creatinine during the first 7 days after surgery as post-operative measurement. Post-operative AKI was defined using the KDIGO criteria. Patients must have had at least Stage 1 AKI, defined as a rise in serum creatinine of 26.5 lmol/L or more or a post-operative serum creatinine of >150% of baseline serum creatinine, to be classified as having post-operative AKI [10] .
Statistical methods
Baseline characteristics were displayed as mean and standard deviation (SD) for continuous variables. Categorical variables were displayed as number and percentage. SIMD deprivation and days of CM exposure before surgery were displayed as number and percentage for each category but were included into further analyses as continuous variables.
The cohort was comprised of all patients who had undergone surgical procedures and radiological investigations involving the administration of CM in the Tayside region of Scotland. The index date of entry was the date of admission prior to the surgical procedure and the follow-up period was for 7 days. The primary outcome was AKI and was analysed using logistic regression with AKI as a binary outcome in the 7 days after surgery. Variables that entered into the multiple logistic regression analysis were: age, gender, SIMD deprivation, baseline renal function, diabetes, prescription of angiotensin-converting enzyme (ACE) inhibitors or angiotensin receptor blockers (ARBs), prescription of HMG-Co reductase inhibitors (statins), prescription of Non-steroidal anti-inflammatory drugs (NSAIDs), prescription of loop diuretics and days of CM exposure before surgery. Baseline renal function was assessed using estimated glomerular filtration rate (eGFR), which was calculated using the CKD-EPI equation [11] . The rates were then categorized as <29, 30-44, 45-59 and >60. Missing values of SIMD were imputed using multiple imputations [12] . Results are expressed as odds ratios (OR) and their 95% confidence intervals (CI). In addition, ordinal logistic regression was carried out with the outcome as the three stages of AKI in order to assess whether any of the variables were associated with severity of AKI. Analyses were implemented in Statistical Analysis Software (SAS v9.3).
R E S U L T S
Between 1 January 2003 and 31 December 2013, 13 482 patients in the Tayside region of Scotland underwent surgery and also had diagnostic imaging investigations performed. Among the 13 482 patients, only 9300 had serum creatinine (SCr) tested within 6 months before and 7 days after surgery. Of these 9300 patients, 6224 were exposed to CM in the immediate perioperative period and 3076 were not. Postoperative AKI occurred in 678 (10.9%) of the 6224 patients who were exposed to CM. Of these, 540 were Stage 1, 91 Stage 2 and 47 Stage 3.
Baseline demographics
Baseline characteristics of patients exposed to and not exposed to CM with and without AKI are shown in Table 1 Contrast media and risk of AKI Post-operative AKI occurred in 678 (10.9%) of the 6300 patients who were exposed to CM and 329 (10.7%) of the 3076 not exposed to contrast. Relative risk of developing AKI in the patients exposed to CM was 1.018 (95% CI 0.899-1.153).
Predictive variables for AKI
Results from multiple logistic regression are shown in Table 2 . After entering 10 variables into the multiple logistic regression model, independent predictors of post-operative AKI were increasing age, male gender, lower baseline renal function and treatment with ACE inhibitors or ARBs. Timing of CM exposure did not affect risk of developing AKI, OR 0.972 (95% CI 0.935-1.010), P ¼ 0.146.
Ordinal logistic regression for stages of post-operative AKI
Results of ordinal logistic regression with stage of AKI as the outcome are shown in Table 3 . Only baseline renal function was significantly associated with the severity of post-operative AKI. The time in days btween use of CM and surgery exposure after adjustment for baseline renal function did not significantly impact the severity of post-operative AKI OR 0.907 (95% CI 0.823-1.000), P ¼ 0.051.
D I S C U S S I O N
We have demonstrated that exposure to CM appears to confer little or no additional risk of AKI in patients undergoing general surgical procedures. In contrast, several other wellknown risk factors for AKI such as male gender, baseline renal function, presence of diabetes and treatment with ACE inhibitors and ARBs remained strong predictors of AKI in this clinical setting.
Iodinated radiological CM are known to be nephrotoxic so it is perhaps surprising that this nephrotoxic effect does not appear to add appreciably to the risk of developing AKI in patients undergoing general surgical procedures. It seems unlikely that the nephrotoxic effects of CM are mitigated by the physiolological insults of surgery and the underlying medical conditions precipitating the need for surgery. It may be that the the physiological derangements related to the surgery and underlying patient co-morbidities play a greater role than the effect of exposure to CM. For this to be the case the additional nephrotoxic effect of CM exposure in this clinical setting must be small and, for all practical purposes, negligible for these patients.
A recent large study of almost 8 million hospitalized patients in 2009 in the USA showed that CM exposure was not associated with an increased risk of AKI. The authors concluded that the risk of CIN may be overstated in the literature and overestimated by clinicians [13] . An accompanying editorial suggested 'it may be appropriate to moderately liberalize the overall use of contrast' whilst continuing to carefully weigh the potential benefits versus the risks of the procedure [14] . This study was, however, limited by the fact that AKI was defined using International Classification of Diseases (ICD)-9 codes perhaps underestimating its incidence. Another large study reported that CM exposure in the absence of pre-existing CKD was not associated with increased risk of AKI [15] . A smaller study of 100 hospitalized patients with stable renal function found similarly that AKI following CM exposure was rare in the absence of confounding risk factors such as nephrotoxic medications and CKD [16] . Our findings that CM exposure did not add appreciably to the risk of AKI in patients undergoing surgery lends support to the suggestion that the influence of CM exposure alone on the risk of AKI may be clinically insignificant where other risk factors are present. The current study draws data from a 12-year time period during which both awareness of CIN and preventive measures have evolved. Although impossible to define numerically, during the study period, there has undoubtedly been increasing clinician awareness of CIN, leading to the development of several collaborative 'renal protection' protocols that appeared to be better adhered to than dictate emanating unilaterally from the department of radiology. Changes in information technology have also facilitated a more considered approach to patients with impaired renal function. These include improvements in the hospital information systems (HIS) allowing easier access to up-to-date blood results and integration of HIS with the radiology information system (RIS). This allows the radiology department staff to view the most recent eGFR results for patients at the time of appointing radiological procedures. This facilitates discussion and management of patients with impaired renal function undergoing contrast-enhanced scans. Advance consideration of challenging cases would sometimes result in deferred radiological examinations, careful fluid management around the time of CM administration or even alteration of investigation plans to utilize tests that avoid CM altogether.
A 'renal protection' guideline was implemented in 2012 in Tayside. This recommended administering either 0.9% saline for 12 h pre-and post-scan or 1.26% sodium bicarbonate for 1 h pre-and 6 h post-scan in high-risk patients. Prior to 2012, there was no hospital-wide guideline in place and so practice varied considerably. Contrast agents used during the study period included iopamidol, iopromide and iohexol. Iso-osmolar agents reported to be associated with reduced risk of renal impairment were employed in a very small number of patients (dozens) in the mid-2000s but this approach did not follow any planned protocol and was not recorded in any readily accessible database format [17] .
Strengths of our study include the large cohort size and the use of the widely accepted KDIGO criteria to define AKI allowing inclusion of milder forms of AKI. However, our study is limited by the use of routinely collected data preventing the inclusion of intra-operative factors, exact dose of contrast administration and inpatient prescribing, which may influence risk of AKI. In addition our population was predominantly Caucasian and so our findings may not be applicable to other ethnicities. We were unable to use data on comorbidities due to under-reporting [18] . We therefore used a number of prescribed medications prior to admission, which has been shown to correlate well with comorbidity [19] .
CT scanning has become the workhorse imaging investigation in hospitalized patients with abdominal and cardiovascular disease [20, 21] . Although CT of the abdomen can be performed without intravenous CM, the use of CM facilitates good accuracy and a high level of diagnostic confidence [21] . Although radiology staff are generally aware of CIN and its risk factors, it has been suggested that more could be done by radiologists and referring physicians to reduce the risk of CIN [22] . Anecdotally we are aware that radiologists often avoid administering intravenous CM during CT scanning of patients who are considered to be at risk of CIN, and again anecodotally we are aware that radiologists consider such CT scans to be of substantially poorer diagnostic utility than CT scans performed with intravenous CM.
An episode of AKI, even after biochemical resolution, is associated with long-term consequences such as greater risk of readmission, development and progression of CKD, and poorer long-term survival. In addition to these adverse health outcomes, AKI has a significant economic impact. Increased costs are due to increased length of hospital inpatients stay, increased investigation, intensive care admission and RRT. In the UK the cost of in-hospital AKI alone (not including AKI in the community) is estimated to be between £434 and £620 million per year [23] .
In the field of cardiac surgery a strong relationship has been demonstrated between synchronous CM exposure and high CM volumes and an increased risk of post-operative AKI [7] . Dose-response relationships have been demonstrated between the risk of AKI and (i) close timing of angiography and surgery [7] and (ii) the amount of CM administered [24] . A significant association has been identified between AKI and volume of CM exposure at endovascular aneurysm repair, with a corresponding deleterious effect on in-hospital mortality [25] .
These data is lacking in the field of non-cardiac surgery where the usual source of CM exposure is CT scanning. CMenhanced CT scans are commonly performed on patients undergoing non-cardiac surgery in both the preoperative and post-operative periods. CM-enhanced CT scans and angiography are commonly performed in the immediate pre-and postoperative periods, especially in the more vulnerable group of patients undergoing emergency surgery.
Shorter intervals between CM exposure and surgery were not associated with an increase in the risk of post-operative AKI. However, male gender, baseline renal function, presence of diabetes and treatment with ACE inhibitors and ARBs were significant predictors of post-operative AKI. For patients who have either just had or are soon to undergo general surgical procedures there appears to be no need to limit CT scan quality by avoiding the administration of CM. These patients may benefit from the increased diagnostic utility of contrast-enhanced CT scans without increasing their risk of perioperative AKI.
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